[
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-05 06:15:00",
    "publisher": "The Motley Fool",
    "title": "Here's What to Do When a Stock You Own Sparks Controversy",
    "image": "https://images.financialmodelingprep.com/news/heres-what-to-do-when-a-stock-you-own-20211005.jpg",
    "site": "fool.com",
    "text": "If you plan ahead, you won't make a costly mistake when there's a kerfuffle.",
    "url": "https://www.fool.com/investing/2021/10/05/heres-what-to-do-when-a-stock-you-own-sparks-contr/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-05T06:15:00-04:00",
    "date_et": "2021-10-05"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-05 06:30:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-announces-submission-of-emergency-use-authorization-amendment-20211005.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., Oct. 5, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) announced it has submitted data to the U.S. Food and Drug Administration (FDA) to support use of a booster shot of the Johnson & Johnson COVID-19 vaccine in individuals 18 years of age and older.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-announces-submission-of-emergency-use-authorization-amendment-to-the-us-fda-to-support-booster-of-its-single-shot-covid-19-vaccine-301392683.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-05T06:30:00-04:00",
    "date_et": "2021-10-05"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-05 06:42:09",
    "publisher": "Market Watch",
    "title": "J&J amends FDA EUA submission for COVID-19 booster with data showing 94% protection against moderate to severe illness",
    "image": "https://images.financialmodelingprep.com/news/jj-amends-fda-eua-submission-for-covid19-booster-with-20211005.jpg",
    "site": "marketwatch.com",
    "text": "Johnson & Johnson JNJ, -0.78% said Tuesday it has submitted an amendment to the emergency use authorization it's seeking from the U.S. Food and Drug Administration for a booster shot of its COVID-19 vaccine with additional data showing it increased protection to 94% against moderate to severe or critical COVID-19 in the U.S.",
    "url": "https://www.marketwatch.com/story/jj-amends-fda-eua-submission-for-covid-19-booster-with-data-showing-94-protection-against-moderate-to-severe-illness-2021-10-05",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-05T06:42:09-04:00",
    "date_et": "2021-10-05"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-05 07:45:01",
    "publisher": "Benzinga",
    "title": "Johnson & Johnson Seeks FDA Emergency Use Nod For COVID-19 Booster Dose",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-seeks-fda-emergency-use-nod-for-covid19-booster-20211005.jpg",
    "site": "benzinga.com",
    "text": "Johnson & Johnson (NYSE: JNJ) has submitted data to the FDA seeking emergency use approval of its single-dose COVID-19 vaccine in individuals 18 years of age and older. The submission includes results from the Phase 3 ENSEMBLE 2 study that booster shot at two months provided 94% protection against symptomatic COVID-19 in the U.S.",
    "url": "https://www.benzinga.com/general/biotech/21/10/23235413/johnson-johnson-seeks-fda-emergency-use-nod-for-covid-19-booster-dose",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-05T07:45:01-04:00",
    "date_et": "2021-10-05"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-05 08:31:00",
    "publisher": "The Motley Fool",
    "title": "Believe It or Not, These Stocks Pay You to Own Them",
    "image": "https://images.financialmodelingprep.com/news/believe-it-or-not-these-stocks-pay-you-to-20211005.jpg",
    "site": "fool.com",
    "text": "Ready to get paid to invest?",
    "url": "https://www.fool.com/investing/2021/10/05/dividend-stocks-pay-you-to-own-them/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-05T08:31:00-04:00",
    "date_et": "2021-10-05"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-05 08:36:43",
    "publisher": "Forbes",
    "title": "Johnson & Johnson Submits Booster Shot Data To FDA For Approval",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-submits-booster-shot-data-to-fda-for-20211005.jpg",
    "site": "forbes.com",
    "text": "The company has released data suggesting the second shot offers strong protection against Covid-19.",
    "url": "https://www.forbes.com/sites/alisondurkee/2021/10/05/johnson--johnson-submits-booster-shot-data-to-fda-for-approval/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-05T08:36:43-04:00",
    "date_et": "2021-10-05"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-05 09:08:07",
    "publisher": "New York Post",
    "title": "Johnson & Johnson seeks emergency approval for COVID booster shot",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-seeks-emergency-approval-for-covid-booster-shot-20211005.jpg",
    "site": "nypost.com",
    "text": "Johnson & Johnson has submitted new data to the Food and Drug Administration in the hopes of securing emergency approval of its COVID-19 vaccine booster shot for people 18 and older.",
    "url": "https://nypost.com/2021/10/05/johnson-johnson-seeks-emergency-approval-for-covid-booster/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-05T09:08:07-04:00",
    "date_et": "2021-10-05"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-05 12:45:10",
    "publisher": "Benzinga",
    "title": "Is Johnson & Johnson's Stock Overvalued Or Undervalued?",
    "image": "https://images.financialmodelingprep.com/news/is-johnson-johnsons-stock-overvalued-or-undervalued-20211005.jpg",
    "site": "benzinga.com",
    "text": "Johnson & Johnson (NYSE: JNJ) shares have lagged the S&P 500 in 2021, generating a year-to-date total return of just 3.6%. Johnson & Johnson has gotten plenty of headlines for its COVID-19 vaccine, but investors may be wondering just how much value is left in the pharma giant's stock?",
    "url": "https://www.benzinga.com/general/education/21/10/23243315/is-johnson-johnsons-stock-overvalued-or-undervalued",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-05T12:45:10-04:00",
    "date_et": "2021-10-05"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-05 22:12:37",
    "publisher": "Seeking Alpha",
    "title": "3 Reasons To Own Johnson & Johnson But Buy These 2 Faster-Growing High-Yield Blue-Chips Today",
    "image": "https://images.financialmodelingprep.com/news/3-reasons-to-own-johnson-johnson-but-buy-these-20211005.jpg",
    "site": "seekingalpha.com",
    "text": "3 Reasons To Own Johnson & Johnson But Buy These 2 Faster-Growing High-Yield Blue-Chips Today",
    "url": "https://seekingalpha.com/article/4458607-3-reasons-own-johnson-and-johnson-but-buy-2-growing-high-yield-blue-chips-today",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-05T22:12:37-04:00",
    "date_et": "2021-10-05"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-06 11:00:00",
    "publisher": "PRNewsWire",
    "title": "Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in Nature",
    "image": "https://images.financialmodelingprep.com/news/janssen-announces-novel-mechanism-of-action-that-shows-promise-20211006.jpg",
    "site": "prnewswire.com",
    "text": "BEERSE, Belgium, Oct. 6, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced today, in collaboration with the KU Leuven Rega Institute and the KU Leuven Centre for Drug Design and Discovery (CD3), the publication of new preclinical data in the journal Nature showing that an early-stage compound with a novel mechanism of action could potentially treat all serotypes of dengue fever and provide a period of protection against acquiring the dengue virus. Janssen is now moving its dengue program into clinical development.",
    "url": "https://www.prnewswire.com/news-releases/janssen-announces-novel-mechanism-of-action-that-shows-promise-against-dengue-in-data-published-in-nature-301394296.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-06T11:00:00-04:00",
    "date_et": "2021-10-06"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-06 19:20:35",
    "publisher": "Zacks Investment Research",
    "title": "J&J (JNJ) Seeks FDA Authorization for COVID-19 Booster Jab",
    "image": "https://images.financialmodelingprep.com/news/jj-jnj-seeks-fda-authorization-for-covid19-booster-jab-20211006.jpg",
    "site": "zacks.com",
    "text": "J&J (JNJ) submits data to the FDA to support an authorization for the booster dose of its single-shot COVID-19 vaccine.",
    "url": "https://www.zacks.com/stock/news/1806387/j-j-jnj-seeks-fda-authorization-for-covid-19-booster-jab",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-06T19:20:35-04:00",
    "date_et": "2021-10-06"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-07 06:35:00",
    "publisher": "The Motley Fool",
    "title": "What Do Mix-and-Match Doses Mean for Vaccine Stocks?",
    "image": "https://images.financialmodelingprep.com/news/what-do-mixandmatch-doses-mean-for-vaccine-stocks-20211007.jpg",
    "site": "fool.com",
    "text": "It'll likely push the revenue of vaccine victors even further.",
    "url": "https://www.fool.com/investing/2021/10/07/what-do-mix-and-match-doses-mean-for-vaccine-stock/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-07T06:35:00-04:00",
    "date_et": "2021-10-07"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-08 11:43:24",
    "publisher": "InvestorPlace",
    "title": "7 Defensive Stocks to Buy and Forget About In Times of Volatility",
    "image": "https://images.financialmodelingprep.com/news/7-defensive-stocks-to-buy-and-forget-about-in-20211008.jpg",
    "site": "investorplace.com",
    "text": "Here's why long-term investors seeking defensive stocks to buy right now may want to consider these top seven options right now. The post 7 Defensive Stocks to Buy and Forget About In Times of Volatility appeared first on InvestorPlace.",
    "url": "https://investorplace.com/2021/10/7-defensive-stocks-to-buy-and-forget-about-in-times-of-volatility/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-08T11:43:24-04:00",
    "date_et": "2021-10-08"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-11 11:56:14",
    "publisher": "CNBC",
    "title": "U.S. moves closer to clearing Moderna and J&J Covid booster shots this week",
    "image": "https://images.financialmodelingprep.com/news/us-moves-closer-to-clearing-moderna-and-jj-covid-booster-20211011.jpeg",
    "site": "cnbc.com",
    "text": "The FDA's vaccine advisory committee meeting come less than a month after U.S. regulators authorized third Covid shots of Pfizer's vaccine.",
    "url": "https://www.cnbc.com/2021/10/11/us-moves-closer-to-clearing-moderna-and-jj-covid-booster-shots-this-week.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-11T11:56:14-04:00",
    "date_et": "2021-10-11"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-11 12:17:30",
    "publisher": "Zacks Investment Research",
    "title": "What Lies Ahead for Dow ETFs in Q3 Earnings?",
    "image": "https://images.financialmodelingprep.com/news/what-lies-ahead-for-dow-etfs-in-q3-earnings-20211011.jpg",
    "site": "zacks.com",
    "text": "With some of the blue-chip companies expected to report an earnings surprise, investors should closely monitor the movement of the Dow ETF.",
    "url": "https://www.zacks.com/stock/news/1809024/what-lies-ahead-for-dow-etfs-in-q3-earnings",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-11T12:17:30-04:00",
    "date_et": "2021-10-11"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-11 16:45:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-participate-in-the-credit-suisse-30th-20211011.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., Oct. 11, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate virtually in the Credit Suisse 30th Annual Healthcare Conference on Wednesday, November 10 th.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-credit-suisse-30th-annual-healthcare-conference-301397171.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-11T16:45:00-04:00",
    "date_et": "2021-10-11"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-12 04:00:00",
    "publisher": "Barron's",
    "title": "FDA Advisory Panel Will Debate J&J and Moderna Boosters This Week",
    "image": "https://images.financialmodelingprep.com/news/fda-advisory-panel-will-debate-jj-and-moderna-boosters-20211012.jpg",
    "site": "barrons.com",
    "text": "Committee members also will hear a presentation on a so-called mix-and-match booster, or a dose of a vaccine different from the original one.",
    "url": "https://www.barrons.com/articles/fda-advisory-panel-will-debate-j-j-and-moderna-boosters-this-week-51634024674",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-12T04:00:00-04:00",
    "date_et": "2021-10-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-12 06:45:00",
    "publisher": "PRNewsWire",
    "title": "Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021",
    "image": "https://images.financialmodelingprep.com/news/dr-paul-stoffels-vice-chairman-of-the-executive-committee-20211012.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., Oct. 12, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that Paul Stoffels M.D.",
    "url": "https://www.prnewswire.com/news-releases/dr-paul-stoffels-vice-chairman-of-the-executive-committee-and-chief-scientific-officer-of-johnson--johnson-to-retire--effective-december-31-2021-301397531.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-12T06:45:00-04:00",
    "date_et": "2021-10-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-12 08:13:00",
    "publisher": "Barron's",
    "title": "FDA Advisory Panel to Debate J&J and Moderna Boosters",
    "image": "https://images.financialmodelingprep.com/news/fda-advisory-panel-to-debate-jj-and-moderna-boosters-20211012.jpg",
    "site": "barrons.com",
    "text": "Committee members also will hear a presentation this week on a so-called mix-and-match booster, or a dose of a vaccine different from the original one.",
    "url": "https://www.barrons.com/articles/moderna-jnj-booster-fda-51634024674",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-12T08:13:00-04:00",
    "date_et": "2021-10-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-12 10:16:03",
    "publisher": "Market Watch",
    "title": "J&J's Stoffels, who managed development of the company's COVID-19 shot, is retiring",
    "image": "https://images.financialmodelingprep.com/news/jjs-stoffels-who-managed-development-of-the-companys-covid19-20211012.jpg",
    "site": "marketwatch.com",
    "text": "Dr. Paul Stoffels, the executive running Johnson & Johnson's COVID-19 vaccine program, announced he will retire at the end of the year, the company said Tuesday. As J&J's chief scientific officer and vice chair of the executive committee, Stoffels is in charge of the company's research and product pipeline.",
    "url": "https://www.marketwatch.com/story/jjs-stoffels-who-managed-development-of-the-companys-covid-19-shot-is-retiring-2021-10-12",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-12T10:16:03-04:00",
    "date_et": "2021-10-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-12 10:58:11",
    "publisher": "Zacks Investment Research",
    "title": "3 Small Biotech Stocks in Focus on World Arthritis Day",
    "image": "https://images.financialmodelingprep.com/news/3-small-biotech-stocks-in-focus-on-world-arthritis-20211012.jpg",
    "site": "zacks.com",
    "text": "Here we discuss three drugs or biotech companies with promising candidates in their pipeline for Arthritis indications.",
    "url": "https://www.zacks.com/stock/news/1809640/3-small-biotech-stocks-in-focus-on-world-arthritis-day",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-12T10:58:11-04:00",
    "date_et": "2021-10-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-12 11:10:34",
    "publisher": "Fox Business",
    "title": "FDA to meet over Moderna, Johnson & Johnson vaccine booster shots",
    "image": "https://images.financialmodelingprep.com/news/fda-to-meet-over-moderna-johnson-johnson-vaccine-booster-20211012.jpg",
    "site": "foxbusiness.com",
    "text": "The U.S. Food and Drug Administration (FDA) will meet this week to debate whether or not extra doses of the Moderna, Inc. and Johnson & Johnson Janssen vaccines should be distributed, to whom and when.",
    "url": "https://www.foxbusiness.com/markets/fda-meet-over-moderna-johnson-johnson-vaccine-booster-shots",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-12T11:10:34-04:00",
    "date_et": "2021-10-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-12 16:15:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-announces-jessica-moore-as-vice-president-of-20211012.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., Oct. 12, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced the appointment of Jessica Moore to Vice President of Investor Relations for Johnson & Johnson, effective November 1, 2021.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-announces-jessica-moore-as-vice-president-of-investor-relations-301398394.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-12T16:15:00-04:00",
    "date_et": "2021-10-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-12 16:29:21",
    "publisher": "Zacks Investment Research",
    "title": "Johnson & Johnson (JNJ) Reports Next Week: Wall Street Expects Earnings Growth",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-reports-next-week-wall-street-expects-20211012.jpg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://www.zacks.com/stock/news/1809823/johnson-johnson-jnj-reports-next-week-wall-street-expects-earnings-growth",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-12T16:29:21-04:00",
    "date_et": "2021-10-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-12 18:48:11",
    "publisher": "Zacks Investment Research",
    "title": "Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-dips-more-than-broader-markets-what-you-20211012.jpeg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) closed the most recent trading day at $157.69, moving -1.6% from the previous trading session.",
    "url": "https://www.zacks.com/stock/news/1809870/johnson-johnson-jnj-dips-more-than-broader-markets-what-you-should-know",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-12T18:48:11-04:00",
    "date_et": "2021-10-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-13 06:45:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson to Host Business Review Highlighting Pharmaceuticals",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-host-business-review-highlighting-pharmaceuticals-20211013.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., Oct. 13, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will hold a Business Review for the investment community on Thursday, November 18, 2021, in which company leaders will share a detailed review of its Pharmaceuticals business, differentiated strategy and robust pipeline, and long-term growth outlook.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-to-host-business-review-highlighting-pharmaceuticals-301398928.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-13T06:45:00-04:00",
    "date_et": "2021-10-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-13 10:19:05",
    "publisher": "CNBC",
    "title": "FDA scientists strike favorable tone on J&J Covid booster shots ahead of vote this week",
    "image": "https://images.financialmodelingprep.com/news/fda-scientists-strike-favorable-tone-on-jj-covid-booster-20211013.jpg",
    "site": "cnbc.com",
    "text": "",
    "url": "https://www.cnbc.com/2021/10/13/jj-covid-booster-shot-fda-scientists-strike-favorable-tone-ahead-of-vote-this-week.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-13T10:19:05-04:00",
    "date_et": "2021-10-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-13 13:43:16",
    "publisher": "Seeking Alpha",
    "title": "5 High-Yield Dividend Aristocrats That Are Perfect For Sinking Markets",
    "image": "https://images.financialmodelingprep.com/news/5-highyield-dividend-aristocrats-that-are-perfect-for-sinking-20211013.jpg",
    "site": "seekingalpha.com",
    "text": "The debt ceiling crisis has helped cause a healthy pullback but could result in a 10% to 20% correction in the next few weeks.",
    "url": "https://seekingalpha.com/article/4459712-high-yield-dividend-aristocrats-perfect-for-sinking-markets",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-13T13:43:16-04:00",
    "date_et": "2021-10-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-13 14:19:20",
    "publisher": "Schaeffers Research",
    "title": "Johnson & Johnson Gears up for Earnings, FDA Decision Looms",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-gears-up-for-earnings-fda-decision-looms-20211013.jpg",
    "site": "schaeffersresearch.com",
    "text": "Pharmaceutical giant Johnson & Johnson (NYSE:JNJ) is in the spotlight today, after the U.S. Food and Drug Administration (FDA) struck a more favorable tone regarding the company's Covid-19 vaccine booster shot, just a few days before an FDA advisory panel is set to vote on whether the data submitted by Johnson & Johnson supports the need for a booster.",
    "url": "https://www.schaeffersresearch.com/content/analysis/2021/10/13/johnson-johnson-gears-up-for-earnings-fda-decision-looms",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-13T14:19:20-04:00",
    "date_et": "2021-10-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-13 14:24:06",
    "publisher": "Forbes",
    "title": "FDA Says J&J Covid Booster Likely Boosts Immunity, But Evidence Isn't Full-Proof",
    "image": "https://images.financialmodelingprep.com/news/fda-says-jj-covid-booster-likely-boosts-immunity-but-20211013.jpg",
    "site": "forbes.com",
    "text": "An advisory panel will review the argument for second Johnson & Johnson doses Friday.",
    "url": "https://www.forbes.com/sites/carlieporterfield/2021/10/13/fda-says-jj-covid-booster-likely-boosts-immunity-but-evidence-isnt-full-proof/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-13T14:24:06-04:00",
    "date_et": "2021-10-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-13 14:29:23",
    "publisher": "CNBC",
    "title": "J&J Covid vaccine recipients are better off getting Pfizer or Moderna booster, NIH study suggests",
    "image": "https://images.financialmodelingprep.com/news/jj-covid-vaccine-recipients-are-better-off-getting-pfizer-20211013.jpeg",
    "site": "cnbc.com",
    "text": "",
    "url": "https://www.cnbc.com/2021/10/13/jj-covid-vaccine-recipients-are-better-off-getting-pfizer-or-moderna-booster-nih-study-suggests.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-13T14:29:23-04:00",
    "date_et": "2021-10-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-13 21:48:29",
    "publisher": "Seeking Alpha",
    "title": "Buffett Loves These 4 High-Yield Dividend Aristocrats And So Will You",
    "image": "https://images.financialmodelingprep.com/news/buffett-loves-these-4-highyield-dividend-aristocrats-and-so-20211013.jpg",
    "site": "seekingalpha.com",
    "text": "Buffett Loves These 4 High-Yield Dividend Aristocrats And So Will You",
    "url": "https://seekingalpha.com/article/4459771-warren-buffett-loves-these-4-high-yield-dividend-aristocrats-and-so-will-you",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-13T21:48:29-04:00",
    "date_et": "2021-10-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-14 02:25:32",
    "publisher": "Forbes",
    "title": "J&J Covid-19 Vaccine Recipients May Benefit More From Pfizer Or Moderna Boosters, Study Finds",
    "image": "https://images.financialmodelingprep.com/news/jj-covid19-vaccine-recipients-may-benefit-more-from-pfizer-or-20211014.jpg",
    "site": "forbes.com",
    "text": "J&J recipients who were administered Moderna or Pfizer boosters showed significantly higher antibody counts compared to those who received a booster of the same vaccine.",
    "url": "https://www.forbes.com/sites/siladityaray/2021/10/14/jj-covid-19-vaccine-recipients-may-benefit-more-from-pfizer-or-moderna-boosters-study-finds/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-14T02:25:32-04:00",
    "date_et": "2021-10-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-14 17:55:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson Takes Steps to Equitably Resolve All Current and Future Talc Claims",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-takes-steps-to-equitably-resolve-all-current-20211014.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., Oct. 14, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced that LTL Management LLC (LTL), a newly created and separate subsidiary of Johnson & Johnson, that was established to hold and manage claims in the cosmetic talc litigation, has filed for voluntary Chapter 11 bankruptcy protection.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-takes-steps-to-equitably-resolve-all-current-and-future-talc-claims-301400916.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-14T17:55:00-04:00",
    "date_et": "2021-10-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-14 18:15:00",
    "publisher": "Reuters",
    "title": "J&J unit to manage talc claims files for bankruptcy protection",
    "image": "https://images.financialmodelingprep.com/news/jj-unit-to-manage-talc-claims-files-for-bankruptcy-20211014.jpg",
    "site": "reuters.com",
    "text": "Johnson & Johnson said on Thursday its newly created unit that was established to hold and manage claims in the Baby Powder litigation, has filed for voluntary Chapter 11 bankruptcy protection.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-unit-manage-talc-claims-files-bankruptcy-protection-2021-10-14/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-14T18:15:00-04:00",
    "date_et": "2021-10-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-14 22:38:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson Ovarian Cancer Victims Vow Fight to Stop J&J's Bankruptcy Scheme",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-ovarian-cancer-victims-vow-fight-to-stop-20211014.jpg",
    "site": "prnewswire.com",
    "text": "CHARLOTTE, N.C., Oct. 14, 2021 /PRNewswire/ -- Lawyers who represent more than 30,000 women who have filed lawsuits against Johnson & Johnson (NYSE:JNJ) in connection with its defective talc body powders, including the iconic Johnson's Baby Powder, say they will resist J&J's decision to use bankruptcy to avoid legal responsibility for the cancers tied to those products.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-ovarian-cancer-victims-vow-fight-to-stop-jjs-bankruptcy-scheme-301400995.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-14T22:38:00-04:00",
    "date_et": "2021-10-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 06:05:00",
    "publisher": "The Motley Fool",
    "title": "Could Johnson & Johnson's Booster Opportunity Be Better Than Pfizer's and Moderna's?",
    "image": "https://images.financialmodelingprep.com/news/could-johnson-johnsons-booster-opportunity-be-better-than-pfizers-20211015.jpg",
    "site": "fool.com",
    "text": "The bar could be lower for the FDA to authorize booster shots for J&J's COVID-19 vaccine.",
    "url": "https://www.fool.com/investing/2021/10/15/could-johnson-johnsons-booster-opportunity-be-bett/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T06:05:00-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 06:15:05",
    "publisher": "Proactive Investors",
    "title": "J&J puts talc claims subsidiary into bankruptcy",
    "image": "https://images.financialmodelingprep.com/news/jj-puts-talc-claims-subsidiary-into-bankruptcy-20211015.jpg",
    "site": "proactiveinvestors.co.uk",
    "text": "Johnson & Johnson has filed for voluntary Chapter 11 bankruptcy protection for a subsidiary set up to handle legal claims over allegations that the drugmaker's Baby Powder and other cosmetic talc products contain asbestos and cause cancer. J&J is facing litigation from tens of thousands of people, including women suffering from ovarian cancer and mesothelioma.",
    "url": "https://www.proactiveinvestors.co.uk//companies/news/963333/jj-puts-talc-claims-subsidiary-into-bankruptcy-963333.html?SNAPI",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T06:15:05-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 08:46:46",
    "publisher": "Business Insider",
    "title": "What's in store for Moderna and J&J booster shots",
    "image": "https://images.financialmodelingprep.com/news/whats-in-store-for-moderna-and-jj-booster-shots-20211015.jpg",
    "site": "businessinsider.com",
    "text": "These are Insider's biggest healthcare stories for the week ending October 15.",
    "url": "https://www.businessinsider.com/insiders-top-healthcare-stories-for-the-week-ending-october-15-2021-10",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T08:46:46-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 10:46:09",
    "publisher": "Invezz",
    "title": "Explained here why Johnson & Johnson is setting a $2 billion trust",
    "image": "https://images.financialmodelingprep.com/news/explained-here-why-johnson-johnson-is-setting-a-2-20211015.jpg",
    "site": "invezz.com",
    "text": "Johnson & Johnson (NYSE: JNJ) put its obligations for tens of thousands of cases tying talc-based products to cancer into bankruptcy. The company hopes the action will help push a personal injury claims settlement.",
    "url": "https://invezz.com/news/2021/10/15/explained-here-why-johnson-johnson-is-setting-a-2-billion-trust/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T10:46:09-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 11:38:58",
    "publisher": "24/7 Wall Street",
    "title": "Earnings Previews: Halliburton, Johnson & Johnson, Philip Morris, Procter & Gamble, Steel Dynamics",
    "image": "https://images.financialmodelingprep.com/news/earnings-previews-halliburton-johnson-johnson-philip-morris-procter-gamble-20211015.jpg",
    "site": "247wallst.com",
    "text": "The first week of the September-quarter earnings season is now in the books. At a glance, of 24 companies we followed that reported quarterly results this week, only two missed profit estimates and only three missed revenue forecasts.",
    "url": "https://247wallst.com/investing/2021/10/15/earnings-previews-halliburton-johnson-johnson-philip-morris-procter-gamble-steel-dynamics/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T11:38:58-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 13:36:04",
    "publisher": "CNBC",
    "title": "FDA panel unanimously recommends J&J Covid booster shots to adults who already got the first dose",
    "image": "https://images.financialmodelingprep.com/news/fda-panel-unanimously-recommends-jj-covid-booster-shots-to-adults-20211015.jpeg",
    "site": "cnbc.com",
    "text": "",
    "url": "https://www.cnbc.com/2021/10/15/fda-panel-unanimously-recommends-jj-covid-booster-shots-to-millions-of-americans.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T13:36:04-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 13:39:00",
    "publisher": "Market Watch",
    "title": "FDA committee says it's safe for all adults who got J&J's COVID-19 vaccine to get a booster",
    "image": "https://images.financialmodelingprep.com/news/fda-committee-says-its-safe-for-all-adults-who-20211015.jpg",
    "site": "marketwatch.com",
    "text": "The Food and Drug Administration should authorize a second “booster” dose of Johnson & Johnson's JNJ, +0.89% COVID-19 vaccine for adults who were initially vaccinated with this vaccine, according to a group of scientists and clinicians that advises the regulator.",
    "url": "https://www.marketwatch.com/story/fda-committee-says-its-safe-for-all-adults-who-got-j-js-covid-19-vaccine-to-get-a-booster-11634319561",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T13:39:00-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 13:46:55",
    "publisher": "Forbes",
    "title": "FDA Advisory Committee Recommends Booster Shots Of J&J Vaccine For People 18 And Older",
    "image": "https://images.financialmodelingprep.com/news/fda-advisory-committee-recommends-booster-shots-of-jj-vaccine-for-20211015.jpg",
    "site": "forbes.com",
    "text": "The recommendation of the independent panel of experts is typically followed by the FDA.",
    "url": "https://www.forbes.com/sites/jemimamcevoy/2021/10/15/fda-advisory-committee-recommends-booster-shots-of-jj-vaccine-for-people-18-and-older/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T13:46:55-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 14:17:49",
    "publisher": "Business Insider",
    "title": "CDC data confirms J&J is the worst-performing COVID-19 vaccine in the US - but being unvaccinated is far more dangerous",
    "image": "https://images.financialmodelingprep.com/news/cdc-data-confirms-jj-is-the-worstperforming-covid19-vaccine-in-20211015.jpg",
    "site": "businessinsider.com",
    "text": "The CDC has released data breaking down COVID-19 cases and deaths by vaccination status, as well as vaccine brand.",
    "url": "https://www.businessinsider.com/cdc-jj-vaccine-doesnt-protect-as-well-as-moderna-pfizer-2021-10",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T14:17:49-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 14:57:00",
    "publisher": "CNET",
    "title": "FDA panel recommends Johnson & Johnson COVID booster for people 18 and up",
    "image": "https://images.financialmodelingprep.com/news/fda-panel-recommends-johnson-johnson-covid-booster-for-people-18-20211015.jpg",
    "site": "cnet.com",
    "text": "The advisers unanimously voted that those who got the one-dose vaccine should get a booster at least two months later.",
    "url": "https://www.cnet.com/news/fda-panel-recommends-johnson-johnson-covid-booster-for-people-18-and-up/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T14:57:00-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 16:11:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-covid19-vaccine-booster-shot-unanimously-recommended-for-20211015.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., Oct. 15, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted 19-0 to recommend Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following initial vaccination with the single-shot vaccine.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-covid-19-vaccine-booster-shot-unanimously-recommended-for-emergency-use-authorization-by-us-fda-advisory-committee-301401523.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T16:11:00-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 17:04:44",
    "publisher": "CNBC",
    "title": "Scientists question FDA on 'scant' J&J booster data and speedy review",
    "image": "https://images.financialmodelingprep.com/news/scientists-question-fda-on-scant-jj-booster-data-and-20211015.jpeg",
    "site": "cnbc.com",
    "text": "",
    "url": "https://www.cnbc.com/2021/10/15/scientists-question-fda-on-scant-jj-booster-data-and-speedy-review.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T17:04:44-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 17:05:12",
    "publisher": "Business Insider",
    "title": "J&J boosters are on the horizon for everyone who got that shot - regardless of age, job, or health",
    "image": "https://images.financialmodelingprep.com/news/jj-boosters-are-on-the-horizon-for-everyone-who-20211015.jpg",
    "site": "businessinsider.com",
    "text": "Millions of Americans are likely to get Johnson & Johnson boosters now that the FDA's expert panel has unanimously recommended it.",
    "url": "https://www.businessinsider.com/jj-boosters-likely-to-be-authorized-for-all-2021-10",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T17:05:12-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-15 18:45:03",
    "publisher": "Zacks Investment Research",
    "title": "Into the Heart of Q3 Earnings Season",
    "image": "https://images.financialmodelingprep.com/news/into-the-heart-of-q3-earnings-season-20211015.jpg",
    "site": "zacks.com",
    "text": "The big banks got us off to a flying start in this Q3 earnings season, but we will get a true sense of how good or otherwise the corporate profitability picture is after seeing the coming week's reporting docket.",
    "url": "https://www.zacks.com/commentary/1811129/into-the-heart-of-q3-earnings-season",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-15T18:45:03-04:00",
    "date_et": "2021-10-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-16 05:51:00",
    "publisher": "The Motley Fool",
    "title": "The Safest Stocks to Buy if There's a Stock Market Crash",
    "image": "https://images.financialmodelingprep.com/news/the-safest-stocks-to-buy-if-theres-a-stock-20211016.jpg",
    "site": "fool.com",
    "text": "This stock trio is perfectly positioned to help investors navigate a possible downturn.",
    "url": "https://www.fool.com/investing/2021/10/16/safest-stocks-to-buy-if-theres-stock-market-crash/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-16T05:51:00-04:00",
    "date_et": "2021-10-16"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-16 06:01:00",
    "publisher": "The Motley Fool",
    "title": "Will Johnson & Johnson Win Authorization for Its COVID-19 Booster?",
    "image": "https://images.financialmodelingprep.com/news/will-johnson-johnson-win-authorization-for-its-covid19-booster-20211016.jpg",
    "site": "fool.com",
    "text": "It's highly likely.",
    "url": "https://www.fool.com/investing/2021/10/16/will-johnson-johnson-win-authorization-for-its-cov/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-16T06:01:00-04:00",
    "date_et": "2021-10-16"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-17 05:57:00",
    "publisher": "The Motley Fool",
    "title": "3 Dividend Stocks to Buy If the Stock Market Crashes",
    "image": "https://images.financialmodelingprep.com/news/3-dividend-stocks-to-buy-if-the-stock-market-20211017.jpg",
    "site": "fool.com",
    "text": "They're resilient and already offer attractive dividends.",
    "url": "https://www.fool.com/investing/2021/10/17/3-dividend-stocks-to-buy-if-the-stock-market-crash/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-17T05:57:00-04:00",
    "date_et": "2021-10-17"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-17 06:56:02",
    "publisher": "Invezz",
    "title": "Should I buy Johnson & Johnson shares ahead of third-quarter earnings results?",
    "image": "https://images.financialmodelingprep.com/news/should-i-buy-johnson-johnson-shares-ahead-of-thirdquarter-20211017.jpg",
    "site": "invezz.com",
    "text": "Johnson & Johnson (NYSE: JNJ) shares have weakened from their recent highs above $180, and the current share price stands at $161. Johnson & Johnson is scheduled to announce third-quarter earnings results on Tuesday, October 19th, before the market opens, and according to estimates, the company should post strong earnings results.",
    "url": "https://invezz.com/news/2021/10/17/should-i-buy-johnson-johnson-shares-ahead-of-third-quarter-earnings-results/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-17T06:56:02-04:00",
    "date_et": "2021-10-17"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-18 06:05:00",
    "publisher": "The Motley Fool",
    "title": "2 Top Biotech Stocks to Buy in October",
    "image": "https://images.financialmodelingprep.com/news/2-top-biotech-stocks-to-buy-in-october-20211018.jpg",
    "site": "fool.com",
    "text": "These two biotech stocks trade at reasonable valuations and will turbocharge your income portfolio.",
    "url": "https://www.fool.com/investing/2021/10/18/2-top-biotech-stocks-to-buy-in-october/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-18T06:05:00-04:00",
    "date_et": "2021-10-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-18 06:20:00",
    "publisher": "The Motley Fool",
    "title": "2 Top Stocks for a Solid Portfolio Foundation",
    "image": "https://images.financialmodelingprep.com/news/2-top-stocks-for-a-solid-portfolio-foundation-20211018.jpg",
    "site": "fool.com",
    "text": "This mobile device mogul and healthcare hero can help your portfolio weather the stock market's storms.",
    "url": "https://www.fool.com/investing/2021/10/18/3-top-dividend-stocks-for-a-solid-portfolio-founda/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-18T06:20:00-04:00",
    "date_et": "2021-10-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-18 06:45:00",
    "publisher": "Forbes",
    "title": "Will Johnson & Johnson Stock Rise After Q3 Results?",
    "image": "https://images.financialmodelingprep.com/news/will-johnson-johnson-stock-rise-after-q3-results-20211018.jpg",
    "site": "forbes.com",
    "text": "Johnson & Johnson stock is scheduled to report its Q3 2021 results on Tuesday, October 19. We expect J&J to report revenues and earnings slightly above the consensus estimates.",
    "url": "https://www.forbes.com/sites/greatspeculations/2021/10/18/will-johnson--johnson-stock-rise-after-q3-results/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-18T06:45:00-04:00",
    "date_et": "2021-10-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-18 07:53:45",
    "publisher": "Business Insider",
    "title": "We're getting closer to a J&J booster shot",
    "image": "https://images.financialmodelingprep.com/news/were-getting-closer-to-a-jj-booster-shot-20211018.jpg",
    "site": "businessinsider.com",
    "text": "These are Insider's biggest healthcare stories for October 18.",
    "url": "https://www.businessinsider.com/insiders-top-healthcare-stories-for-october-18-2021-10",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-18T07:53:45-04:00",
    "date_et": "2021-10-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-18 08:30:44",
    "publisher": "Benzinga",
    "title": "Johnson & Johnson's COVID-19 Booster Dose Wins FDA Adcomm Backing",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-covid19-booster-dose-wins-fda-adcomm-backing-20211018.jpg",
    "site": "benzinga.com",
    "text": "The FDA's Vaccines and Related Biological Products Advisory Committee voted 19-0 to authorize a second shot of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine to follow at least two months after the initial dose. Related Link:   Johnson & Johnson COVID-19 Booster Shot Generates 9X Spike-Binding Antibodies, Early Data Shows.",
    "url": "https://www.benzinga.com/general/biotech/21/10/23415039/johnson-johnsons-covid-19-booster-dose-wins-fda-adcomm-backing",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-18T08:30:44-04:00",
    "date_et": "2021-10-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 05:52:00",
    "publisher": "The Motley Fool",
    "title": "Why Johnson & Johnson Will Be a Bigger Winner With Boosters Than Pfizer and Moderna",
    "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-will-be-a-bigger-winner-with-20211019.jpg",
    "site": "fool.com",
    "text": "At least initially. It could be a different story over the longer term.",
    "url": "https://www.fool.com/investing/2021/10/19/why-johnson-johnson-winner-boosters-pfizer-moderna/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T05:52:00-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 06:25:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson Reports Q3 2021 Results",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-reports-q3-2021-results-20211019.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., Oct. 19, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2021.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-reports-q3-2021-results-301402807.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T06:25:00-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 06:33:00",
    "publisher": "Reuters",
    "title": "J&J raises 2021 profit view, keeps vaccine sales outlook unchanged",
    "image": "https://images.financialmodelingprep.com/news/jj-raises-2021-profit-view-keeps-vaccine-sales-outlook-20211019.jpg",
    "site": "reuters.com",
    "text": "Johnson & Johnson (JNJ.N) on Tuesday raised its adjusted profit forecast for 2021, even as it stuck to its outlook of $2.5 billion in sales from its COVID-19 vaccine this year.",
    "url": "https://www.reuters.com/business/retail-consumer/johnson-johnson-maintains-2021-sales-forecast-covid-19-vaccine-2021-10-19/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T06:33:00-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 06:44:18",
    "publisher": "CNBC",
    "title": "J&J Covid vaccine adds $502 million to third-quarter sales",
    "image": "https://images.financialmodelingprep.com/news/jj-covid-vaccine-adds-502-million-to-thirdquarter-sales-20211019.jpeg",
    "site": "cnbc.com",
    "text": "Johnson & Johnson said it sold $502 million of its Covid-19 vaccine in the third quarter, in its earnings report Tuesday that beat Wall Street's profit and revenue expectations.",
    "url": "https://www.cnbc.com/2021/10/19/covid-and-johnson-johnson-jnj-earnings-q3-2021.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T06:44:18-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 06:47:05",
    "publisher": "Market Watch",
    "title": "J&J beats profit estimates for latest quarter as sales fall short and company raises full-year guidance",
    "image": "https://images.financialmodelingprep.com/news/jj-beats-profit-estimates-for-latest-quarter-as-sales-20211019.jpg",
    "site": "marketwatch.com",
    "text": "Johnson & Johnson shares JNJ, -0.73% rose 1.6% in premarket trading Tuesday, after the consumer goods and pharmaceuticals company posted better-than-expected third-quarter profit and raised its full-year guidance. The New Brunswick, NJ.",
    "url": "https://www.marketwatch.com/story/jj-beats-profit-estimates-for-latest-quarter-as-sales-fall-short-raises-guidance-2021-10-19",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T06:47:05-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 07:04:19",
    "publisher": "Benzinga",
    "title": "Johnson & Johnson Shares Gain After Q3 Earnings Beat Wall Street; Raises FY21 Guidance",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-shares-gain-after-q3-earnings-beat-wall-20211019.jpg",
    "site": "benzinga.com",
    "text": "Johnson & Johnson (NYSE: JNJ) has reported Q3 adjusted earnings of $2.60 per share, up 18% Y/Y over the $2.20 posted a year ago and better than the consensus of $2.36.  Net sales increased 10.6% Y/Y to $23.3 billion, ahead of the consensus of $23.7 billion.",
    "url": "https://www.benzinga.com/general/biotech/21/10/23435518/johnson-johnson-shares-gain-after-q3-earnings-beat-wall-street-raises-fy21-guidance",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T07:04:19-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 07:33:50",
    "publisher": "Market Watch",
    "title": "J&J's COVID-19 shot generated $502 million in sales in the third quarter",
    "image": "https://images.financialmodelingprep.com/news/jjs-covid19-shot-generated-502-million-in-sales-in-20211019.jpg",
    "site": "marketwatch.com",
    "text": "Shares of Johnson & Johnson JNJ, -0.73% were up 0.1% in premarket trading on Tuesday after the company said it brought in $502 million in worldwide sales of its COVID-19 vaccine in the third quarter of 2021 as part of its earnings report. That adds up to a total of $766 million in sales of its COVID-19 shot so far this year.",
    "url": "https://www.marketwatch.com/story/jjs-covid-19-shot-generated-502-million-in-sales-in-the-third-quarter-2021-10-19",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T07:33:50-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 08:50:07",
    "publisher": "New York Post",
    "title": "Johnson & Johnson made $502M from COVID vaccine in third quarter",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-made-502m-from-covid-vaccine-in-third-20211019.jpg",
    "site": "nypost.com",
    "text": "Johnson & Johnson made just $502 million in global sales of its COVID-19 vaccine in the most recent quarter -- falling far short of quarterly revenue from peers Pfizer and Moderna.",
    "url": "https://nypost.com/2021/10/19/johnson-johnson-made-502m-from-covid-vaccine/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T08:50:07-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 09:54:29",
    "publisher": "Invezz",
    "title": "Johnson & Johnson CFO defends sales miss in fiscal Q3",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-cfo-defends-sales-miss-in-fiscal-q3-20211019.jpg",
    "site": "invezz.com",
    "text": "Johnson & Johnson (NYSE: JNJ) beat Wall Street estimates for earnings in the fiscal third quarter despite a slight miss on the sales front. Shares of the company were up 1.0% in premarket trading on raised full-year guidance.",
    "url": "https://invezz.com/news/2021/10/19/johnson-johnson-cfo-defends-sales-miss-in-fiscal-q3/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T09:54:29-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 11:13:22",
    "publisher": "Benzinga",
    "title": "Why Johnson & Johnson Shares Are Trading Higher Today",
    "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-shares-are-trading-higher-today-20211019.jpg",
    "site": "benzinga.com",
    "text": "Johnson & Johnson (NYSE: JNJ) is trading higher Tuesday after the company announced better-than-expected third-quarter earnings results and raised guidance. Johnson & Johnson reported quarterly adjusted earnings of $2.60 per share, which beat the estimate of $2.36 per share.",
    "url": "https://www.benzinga.com/news/earnings/21/10/23443731/why-johnson-johnson-shares-are-trading-higher-today",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T11:13:22-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 12:03:23",
    "publisher": "Zacks Investment Research",
    "title": "Johnson & Johnson (JNJ) Q3 Earnings Beat Estimates",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-q3-earnings-beat-estimates-20211019.jpg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 9.70% and -1.21%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://www.zacks.com/stock/news/1812262/johnson-johnson-jnj-q3-earnings-beat-estimates",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T12:03:23-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 12:41:04",
    "publisher": "Seeking Alpha",
    "title": "Johnson & Johnson (JNJ) Q3 2021 Results - Earnings Call Transcript",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-q3-2021-results-earnings-call-transcript-20211019.jpg",
    "site": "seekingalpha.com",
    "text": "Johnson & Johnson (JNJ) Q3 2021 Results - Earnings Call Transcript",
    "url": "https://seekingalpha.com/article/4460607-johnson-and-johnson-jnj-q3-2021-results-earnings-call-transcript",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T12:41:04-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 14:26:45",
    "publisher": "Benzinga",
    "title": "Which Vaccine Stock Will Benefit Most From FDA's \"Mix And Match\" Approval?",
    "image": "https://images.financialmodelingprep.com/news/which-vaccine-stock-will-benefit-most-from-fdas-mix-20211019.jpg",
    "site": "benzinga.com",
    "text": "On Tuesday, it became clear that the FDA plans to allow for a “mix and match” approach to vaccine booster shots, allowing—as the Europeans have recommended—people who have been vaccinated against Covid-19 to get a booster shot made from different company than the company that gave them their first dose.  In case you suffer from any long Covid-related intellectual deterioration, this means, for example, you can get booster shot from Johnson & Johnson (J&J) or Pfizer even if your first dose was delivered into your arm courtesy of Moderna.",
    "url": "https://www.benzinga.com/markets/21/10/23447987/which-vaccine-stock-will-benefit-most-from-fdas-mix-and-match-approval",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T14:26:45-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 15:10:23",
    "publisher": "Benzinga",
    "title": "3 Biopharma Stocks To Watch Following Johnson & Johnson's Earnings Beat",
    "image": "https://images.financialmodelingprep.com/news/3-biopharma-stocks-to-watch-following-johnson-johnsons-earnings-20211019.jpg",
    "site": "benzinga.com",
    "text": "Johnson & Johnson (NYSE:JNJ) shares are higher Tuesday following the release of its third-quarter results. J&J A Bellwether For The Sector: Given the timing of J&J's earnings release and its portfolio breadth, its earnings often serve as a bellwether for the sector, according to BofA Securities analyst Geoff Meacham.",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/21/10/23443010/3-biopharma-stocks-to-watch-following-johnson-johnsons-earnings-beat",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T15:10:23-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 16:54:52",
    "publisher": "The Motley Fool",
    "title": "Why Johnson & Johnson Shares Trounced the Market Today",
    "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-shares-trounced-the-market-today-20211019.jpg",
    "site": "fool.com",
    "text": "The healthcare giant recorded healthy growth in all three of its business segments and raised its guidance.",
    "url": "https://www.fool.com/investing/2021/10/19/why-johnson-johnson-trounced-the-market-today/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T16:54:52-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 18:43:50",
    "publisher": "Invezz",
    "title": "Should you buy or sell JNJ shares after delivering mixed Q3 results?",
    "image": "https://images.financialmodelingprep.com/news/should-you-buy-or-sell-jnj-shares-after-delivering-20211019.jpg",
    "site": "invezz.com",
    "text": "On Tuesday, Johnson & Johnson (NYSE:JNJ) shares gained 2.4% after announcing its most recent quarterly results. The company reported its fiscal third-quarter earnings per share before markets opened, beating analyst estimates.",
    "url": "https://invezz.com/news/2021/10/19/should-you-buy-or-sell-jnj-shares-after-delivering-mixed-q3-results/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T18:43:50-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-19 18:58:35",
    "publisher": "Zacks Investment Research",
    "title": "2 Blue-Chip Tech Stocks to Buy Before Earnings and Hold",
    "image": "https://images.financialmodelingprep.com/news/2-bluechip-tech-stocks-to-buy-before-earnings-and-20211019.jpg",
    "site": "zacks.com",
    "text": "The episode breaks down Apple and Microsoft ahead of their upcoming financial results to see if investors might want to buy these giant tech stocks right now.",
    "url": "https://www.zacks.com/stock/news/1812924/2-blue-chip-tech-stocks-to-buy-before-earnings-and-hold",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-19T18:58:35-04:00",
    "date_et": "2021-10-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-20 06:00:05",
    "publisher": "InvestorPlace",
    "title": "7 Dividend Stocks To Buy for 2022 and Hold Forever",
    "image": "https://images.financialmodelingprep.com/news/7-dividend-stocks-to-buy-for-2022-and-hold-20211020.jpg",
    "site": "investorplace.com",
    "text": "Buy these dividend stocks and forget them for 10 years, you will win big and should have little to worry about in the interim. The post 7 Dividend Stocks To Buy for 2022 and Hold Forever appeared first on InvestorPlace.",
    "url": "https://investorplace.com/2021/10/7-dividend-stocks-to-buy-for-2022-and-hold-forever/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-20T06:00:05-04:00",
    "date_et": "2021-10-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-20 14:46:00",
    "publisher": "Market Watch",
    "title": "People who got J&J's COVID-19 shot will soon be able to get a booster. Which one should they get?",
    "image": "https://images.financialmodelingprep.com/news/people-who-got-jjs-covid19-shot-will-soon-be-20211020.jpg",
    "site": "marketwatch.com",
    "text": "The 15 million people in the U.S. who got Johnson & Johnson's COVID-19 vaccine may soon have the option to get a second shot of their choosing.",
    "url": "https://www.marketwatch.com/story/people-who-got-j-js-covid-19-shot-will-soon-be-able-to-get-a-booster-which-one-should-they-get-11634755604",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-20T14:46:00-04:00",
    "date_et": "2021-10-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-20 16:56:44",
    "publisher": "CNBC",
    "title": "FDA clears Johnson & Johnson and Moderna booster shots for millions of people",
    "image": "https://images.financialmodelingprep.com/news/fda-clears-johnson-johnson-and-moderna-booster-shots-for-millions-20211020.jpg",
    "site": "cnbc.com",
    "text": "",
    "url": "https://www.cnbc.com/2021/10/20/fda-clears-johnson-johnson-and-moderna-booster-shots-for-millions-of-people.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-20T16:56:44-04:00",
    "date_et": "2021-10-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-20 16:59:01",
    "publisher": "Market Watch",
    "title": "FDA authorizes use of Moderna, Johnson & Johnson vaccine boosters",
    "image": "https://images.financialmodelingprep.com/news/fda-authorizes-use-of-moderna-johnson-johnson-vaccine-boosters-20211020.jpg",
    "site": "marketwatch.com",
    "text": "WASHINGTON — U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.",
    "url": "https://www.marketwatch.com/story/fda-authorizes-mixing-covid-vaccines-backs-moderna-j-j-boosters-01634763730",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-20T16:59:01-04:00",
    "date_et": "2021-10-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-20 17:19:21",
    "publisher": "Business Insider",
    "title": "The FDA just authorized booster shots of Moderna's and Johnson & Johnson's COVID-19 vaccines and is letting users mix and match shots",
    "image": "https://images.financialmodelingprep.com/news/the-fda-just-authorized-booster-shots-of-modernas-and-20211020.jpg",
    "site": "businessinsider.com",
    "text": "The FDA has authorized booster shots for Johnson & Johnson and Moderna's COVID-19 vaccines.",
    "url": "https://www.businessinsider.com/fda-oks-moderna-covid-19-vaccine-boosters-2021-10",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-20T17:19:21-04:00",
    "date_et": "2021-10-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-20 17:37:22",
    "publisher": "Forbes",
    "title": "FDA Approves Moderna And J&J Covid Booster Shots, Signs Off On Mix-And-Match Approach — Here's Who Is Eligible",
    "image": "https://images.financialmodelingprep.com/news/fda-approves-moderna-and-jj-covid-booster-shots-signs-20211020.jpg",
    "site": "forbes.com",
    "text": "All three Covid-19 vaccines now have booster shots authorized — but eligibility for extra doses depends on the specific vaccine.",
    "url": "https://www.forbes.com/sites/joewalsh/2021/10/20/fda-approves-moderna-and-jj-covid-booster-shots-signs-off-on-mix-and-match-approach---heres-who-is-eligible/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-20T17:37:22-04:00",
    "date_et": "2021-10-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-20 18:14:00",
    "publisher": "CNET",
    "title": "FDA authorizes Moderna, Johnson & Johnson booster shots for many Americans",
    "image": "https://images.financialmodelingprep.com/news/fda-authorizes-moderna-johnson-johnson-booster-shots-for-many-americans-20211020.jpg",
    "site": "cnet.com",
    "text": "The administration also said it'll allow eligible people to \"mix and match\" different COVID-19 shots when they get their booster.",
    "url": "https://www.cnet.com/health/fda-authorizes-moderna-johnson-johnson-booster-shots-for-many-americans/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-20T18:14:00-04:00",
    "date_et": "2021-10-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-20 18:38:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-covid19-vaccine-booster-shot-authorized-for-emergency-20211020.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., Oct. 20, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following primary vaccination with single-shot Johnson & Johnson COVID-19 vaccine; and for eligible individuals who received a different authorized or approved COVID-19 vaccine.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-covid-19-vaccine-booster-shot-authorized-for-emergency-use-by-us-fda-301405196.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-20T18:38:00-04:00",
    "date_et": "2021-10-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-21 03:51:51",
    "publisher": "Benzinga",
    "title": "FDA Approves Moderna, Johnson & Johnson Booster And 'Mix And Match' COVID-19 Shots",
    "image": "https://images.financialmodelingprep.com/news/fda-approves-moderna-johnson-johnson-booster-and-mix-and-20211021.jpg",
    "site": "benzinga.com",
    "text": "The U.S. Food and Drug Administration on Wednesday approved booster shots of Moderna Inc.'s (NASDAQ: MRNA) and Jonson & Johnson's (NYSE: JNJ) COVID-19 vaccines as well as authorized “mixing and matching” of the booster doses. What Happened: The FDA said it has approved the booster shots of Moderna's COVID-19 vaccine for recipients aged 65 and older as well as some other vulnerable groups.",
    "url": "https://www.benzinga.com/general/biotech/21/10/23478842/fda-approves-moderna-johnson-johnson-booster-and-mix-and-match-covid-19-shots",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-21T03:51:51-04:00",
    "date_et": "2021-10-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-21 06:34:05",
    "publisher": "Seeking Alpha",
    "title": "Very Bad News For Dividend Investors (And How To Fix It)",
    "image": "https://images.financialmodelingprep.com/news/very-bad-news-for-dividend-investors-and-how-to-20211021.jpeg",
    "site": "seekingalpha.com",
    "text": "Most dividend investors will not be able to retire on their own terms. This is because of a major flaw in the \"dividend growth investing\" philosophy.",
    "url": "https://seekingalpha.com/article/4461011-very-bad-news-dividend-investors-how-to-fix-it",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-21T06:34:05-04:00",
    "date_et": "2021-10-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-21 09:25:00",
    "publisher": "The Motley Fool",
    "title": "If I Could Only Own 1 Healthcare Stock, This Is What It Would Be",
    "image": "https://images.financialmodelingprep.com/news/if-i-could-only-own-1-healthcare-stock-this-20211021.jpg",
    "site": "fool.com",
    "text": "Investing gets simple if you have to put all of your eggs in one basket.",
    "url": "https://www.fool.com/investing/2021/10/21/if-i-could-only-own-1-healthcare-stock-this-is-it/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-21T09:25:00-04:00",
    "date_et": "2021-10-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-21 10:58:04",
    "publisher": "Zacks Investment Research",
    "title": "FDA Approves JNJ & MRNA's COVID-19 Boosters & Mixing of Doses",
    "image": "https://images.financialmodelingprep.com/news/fda-approves-jnj-mrnas-covid19-boosters-mixing-of-doses-20211021.jpg",
    "site": "zacks.com",
    "text": "The FDA authorizes booster doses of COVID-19 vaccines of JNJ and MRNA. It also authorizes a heterologous boosting option which will allow administration of booster dose of any available vaccine irrespective of the primary vaccination regimen.",
    "url": "https://www.zacks.com/stock/news/1814157/fda-approves-jnj-mrna-s-covid-19-boosters-mixing-of-doses",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-21T10:58:04-04:00",
    "date_et": "2021-10-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-21 11:56:46",
    "publisher": "CNBC",
    "title": "CDC says these are the most common side effects people report after getting Moderna, J&J boosters",
    "image": "https://images.financialmodelingprep.com/news/cdc-says-these-are-the-most-common-side-effects-20211021.jpeg",
    "site": "cnbc.com",
    "text": "",
    "url": "https://www.cnbc.com/2021/10/21/cdc-says-these-are-the-most-common-side-effects-people-report-after-getting-moderna-jj-boosters.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-21T11:56:46-04:00",
    "date_et": "2021-10-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-21 12:48:37",
    "publisher": "InvestorPlace",
    "title": "7 Safe Stocks to Own to Hedge Against Inflation",
    "image": "https://images.financialmodelingprep.com/news/7-safe-stocks-to-own-to-hedge-against-inflation-20211021.jpg",
    "site": "investorplace.com",
    "text": "Worried about inflation that's turned out not to be so \"transitory?\" These seven safe stocks may be the place to be right now.",
    "url": "https://investorplace.com/2021/10/7-safe-stocks-to-own-to-hedge-against-inflation/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-21T12:48:37-04:00",
    "date_et": "2021-10-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-21 13:26:20",
    "publisher": "Invezz",
    "title": "Here is why you need to mix and match Moderna and J&J COVID-19 booster shots",
    "image": "https://images.financialmodelingprep.com/news/here-is-why-you-need-to-mix-and-match-20211021.jpg",
    "site": "invezz.com",
    "text": "TThe US health regulators have widened the country's COVID-19 vaccine campaign after the FDA-approved booster shots for Moderna Inc. (NASDAQ: MRNA) and Johnson & Johnson (NYSE: JNJ) vaccines. The FDA also indicated that people could receive a booster shot from either company irrespective of their vaccine before.",
    "url": "https://invezz.com/news/2021/10/21/here-is-why-you-need-to-mix-and-match-moderna-and-jj-covid-19-booster-shots/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-21T13:26:20-04:00",
    "date_et": "2021-10-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-21 14:38:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2021",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-announces-quarterly-dividend-for-fourth-quarter-2021-20211021.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., Oct. 21, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2021 of $1.06 per share on the company's common stock.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-announces-quarterly-dividend-for-fourth-quarter-2021-301406101.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-21T14:38:00-04:00",
    "date_et": "2021-10-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-21 17:18:47",
    "publisher": "CNBC",
    "title": "CDC panel unanimously endorses Moderna and J&J Covid boosters, sending to director for final approval",
    "image": "https://images.financialmodelingprep.com/news/cdc-panel-unanimously-endorses-moderna-and-jj-covid-boosters-20211021.jpeg",
    "site": "cnbc.com",
    "text": "",
    "url": "https://www.cnbc.com/2021/10/21/cdc-panel-unanimously-endorses-moderna-covid-booster-shots-for-same-groups-as-pfizers.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-21T17:18:47-04:00",
    "date_et": "2021-10-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-21 17:24:02",
    "publisher": "Zacks Investment Research",
    "title": "Can Biotech ETFs Gain From Positive Booster Update?",
    "image": "https://images.financialmodelingprep.com/news/can-biotech-etfs-gain-from-positive-booster-update-20211021.jpg",
    "site": "zacks.com",
    "text": "In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.",
    "url": "https://www.zacks.com/stock/news/1814654/can-biotech-etfs-gain-from-positive-booster-update",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-21T17:24:02-04:00",
    "date_et": "2021-10-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-21 17:55:00",
    "publisher": "CNET",
    "title": "CDC panel votes to recommend boosters for Moderna, Johnson & Johnson recipients",
    "image": "https://images.financialmodelingprep.com/news/cdc-panel-votes-to-recommend-boosters-for-moderna-johnson-20211021.jpg",
    "site": "cnet.com",
    "text": "The committee leans into the FDA's authorization of a \"mix and match\" approach to COVID-19 boosters, meaning people wouldn't have to match their original shot.",
    "url": "https://www.cnet.com/health/medical/cdc-panel-votes-on-booster-recommendations-for-moderna-johnson-johnson-recipients/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-21T17:55:00-04:00",
    "date_et": "2021-10-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-21 18:13:39",
    "publisher": "Forbes",
    "title": "CDC Advisors Back Booster Shots For Moderna And J&J's Covid Vaccines",
    "image": "https://images.financialmodelingprep.com/news/cdc-advisors-back-booster-shots-for-moderna-and-jjs-covid-20211021.jpg",
    "site": "forbes.com",
    "text": "An independent advisory board at the CDC says all adults who took Johnson & Johnson's coronavirus vaccine — and some high-risk adults who took Moderna's vaccine — should get an additional dose.",
    "url": "https://www.forbes.com/sites/joewalsh/2021/10/21/cdc-advisors-back-booster-shots-for-moderna-and-jjs-covid-vaccines/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-21T18:13:39-04:00",
    "date_et": "2021-10-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-22 11:01:56",
    "publisher": "InvestorPlace",
    "title": "7 of the Best Dividend Stocks for Passive Income",
    "image": "https://images.financialmodelingprep.com/news/7-of-the-best-dividend-stocks-for-passive-income-20211022.jpg",
    "site": "investorplace.com",
    "text": "Dividend stocks are like the color black: They'll always be in style. Investors love income and that's not going to change moving forward.",
    "url": "https://investorplace.com/2021/10/7-of-the-best-dividend-stocks-for-passive-income/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-22T11:01:56-04:00",
    "date_et": "2021-10-22"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-22 11:15:00",
    "publisher": "Reuters",
    "title": "Walgreens U.S. stores start administering Moderna, J&J COVID-19 booster",
    "image": "https://images.financialmodelingprep.com/news/walgreens-us-stores-start-administering-moderna-jj-covid19-booster-20211022.jpg",
    "site": "reuters.com",
    "text": "(Reuters) -Walgreens Boots Alliance Inc said on Friday its U.S. stores started administering COVID-19 booster shots from Moderna Inc and Johnson & Johnson, a day after the country's health regulator recommended the additional doses.",
    "url": "https://www.reuters.com/article/us-health-coronavirus-boosters/walgreens-u-s-stores-start-administering-moderna-jj-covid-19-booster-idUSKBN2HC1HZ",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-22T11:15:00-04:00",
    "date_et": "2021-10-22"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-22 15:30:22",
    "publisher": "Benzinga",
    "title": "Q3 Earnings Report Recap; TSLA, NFLX, JNJ, PG",
    "image": "https://images.financialmodelingprep.com/news/q3-earnings-report-recap-tsla-nflx-jnj-pg-20211022.jpg",
    "site": "benzinga.com",
    "text": "Q3 earning season is currently underway, and most high-profile companies are delivering revenue beats. Yet, Q3 revenue is not the only thing investors are watching.",
    "url": "https://www.benzinga.com/news/earnings/21/10/23515633/q3-earnings-report-recap-tsla-nflx-jnj-pg",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-22T15:30:22-04:00",
    "date_et": "2021-10-22"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-23 08:00:01",
    "publisher": "CNBC",
    "title": "Covid vaccine boosters are now available. Here's who's eligible for Pfizer, Moderna and J&J's shots",
    "image": "https://images.financialmodelingprep.com/news/covid-vaccine-boosters-are-now-available-heres-whos-eligible-20211023.jpeg",
    "site": "cnbc.com",
    "text": "",
    "url": "https://www.cnbc.com/2021/10/23/covid-vaccine-boosters-are-now-available-heres-whos-eligible-for-pfizer-moderna-and-jjs-shots-.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-23T08:00:01-04:00",
    "date_et": "2021-10-23"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-25 06:50:00",
    "publisher": "The Motley Fool",
    "title": "Does This News Make Johnson & Johnson a Buy?",
    "image": "https://images.financialmodelingprep.com/news/does-this-news-make-johnson-johnson-a-buy-20211025.jpg",
    "site": "fool.com",
    "text": "The company just got some good news from health authorities.",
    "url": "https://www.fool.com/investing/2021/10/25/does-this-news-make-johnson-johnson-a-buy/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-25T06:50:00-04:00",
    "date_et": "2021-10-25"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-25 20:00:13",
    "publisher": "Zacks Investment Research",
    "title": "Buy This Great High-Yield Dividend Stock?",
    "image": "https://images.financialmodelingprep.com/news/buy-this-great-highyield-dividend-stock-20211025.jpg",
    "site": "zacks.com",
    "text": "Investors in search of stable income should consider strong dividend-paying stocks, with solid yields. Pharmaceutical standout AbbVie appears to be worth buying as a long-term play, with it set to release its Q3 results on Friday, October 29.",
    "url": "https://www.zacks.com/stock/news/1816288/buy-this-great-high-yield-dividend-stock",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-25T20:00:13-04:00",
    "date_et": "2021-10-25"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-26 05:35:05",
    "publisher": "Seeking Alpha",
    "title": "Johnson & Johnson: Currently Trading At Fair To Overvalued Territory",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-currently-trading-at-fair-to-overvalued-territory-20211026.jpg",
    "site": "seekingalpha.com",
    "text": "Johnson & Johnson historical performance is exceptional. The company offers a starting forward dividend yield of 2.6% and 59 consecutive years of dividend increases.",
    "url": "https://seekingalpha.com/article/4461950-johnson-and-johnson-trading-fair-overvalued-territory",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-26T05:35:05-04:00",
    "date_et": "2021-10-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-26 07:20:34",
    "publisher": "24/7 Wall Street",
    "title": "5 Dividend Aristocrats Stocks Have Raised Their Dividends for Almost 60 Years",
    "image": "https://images.financialmodelingprep.com/news/5-dividend-aristocrats-stocks-have-raised-their-dividends-for-20211026.jpg",
    "site": "247wallst.com",
    "text": "With October almost over, many investors are looking ahead to Halloween, the holidays and the end of the year.",
    "url": "https://247wallst.com/investing/2021/10/26/5-dividend-aristocrats-stocks-have-raised-their-dividends-for-almost-60-years/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-26T07:20:34-04:00",
    "date_et": "2021-10-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-26 13:55:15",
    "publisher": "Benzinga",
    "title": "Johnson & Johnson Settles Opioid Claims In Texas For $291.8M",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-settles-opioid-claims-in-texas-for-2918m-20211026.jpg",
    "site": "benzinga.com",
    "text": "Johnson & Johnson (NYSE: JNJ) and its U.S.-based Janssen Pharmaceutical Companies have reached a $291.8 million settlement with the Texas state government that resolves its opioid-related claims made against the companies. What Happened: Johnson & Johnson will pay its settlement sum into the Qualified Settlement Fund, which represents Texas's allocation of the Global Prescription Opioid Litigation Settlement Agreement announced on July 23.",
    "url": "https://www.benzinga.com/government/21/10/23566952/johnson-johnson-settles-opioid-claims-in-texas-for-291-8m",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-26T13:55:15-04:00",
    "date_et": "2021-10-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-27 12:58:36",
    "publisher": "Zacks Investment Research",
    "title": "Healthcare ETFs in Focus as Q3 Earnings Unfold",
    "image": "https://images.financialmodelingprep.com/news/healthcare-etfs-in-focus-as-q3-earnings-unfold-20211027.jpg",
    "site": "zacks.com",
    "text": "The healthcare sector is expected to witness substantial earnings growth of 17.5% in the third quarter.",
    "url": "https://www.zacks.com/stock/news/1817615/healthcare-etfs-in-focus-as-q3-earnings-unfold",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-27T12:58:36-04:00",
    "date_et": "2021-10-27"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-27 17:04:19",
    "publisher": "CNBC",
    "title": "1.5 million Americans got a Moderna or J&J Covid booster shot in the first 5 days, White House says",
    "image": "https://images.financialmodelingprep.com/news/15-million-americans-got-a-moderna-or-jj-covid-20211027.jpeg",
    "site": "cnbc.com",
    "text": "\"Our booster program is off to a very strong start,\" Jeff Zients, the White House coronavirus response coordinator, told reporters.",
    "url": "https://www.cnbc.com/2021/10/27/white-house-1point5-million-in-us-got-moderna-or-jj-covid-booster-in-first-5-days.html",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-27T17:04:19-04:00",
    "date_et": "2021-10-27"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-28 06:04:00",
    "publisher": "The Motley Fool",
    "title": "3 Pharma Stocks You Can Buy and Hold Forever",
    "image": "https://images.financialmodelingprep.com/news/3-pharma-stocks-you-can-buy-and-hold-forever-20211028.jpg",
    "site": "fool.com",
    "text": "These drugmakers are built to last.",
    "url": "https://www.fool.com/investing/2021/10/28/3-pharma-stocks-you-can-buy-and-hold-forever/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-28T06:04:00-04:00",
    "date_et": "2021-10-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-28 06:15:00",
    "publisher": "The Motley Fool",
    "title": "2 Top Stocks That Can Help Investors Crush Inflation",
    "image": "https://images.financialmodelingprep.com/news/2-top-stocks-that-can-help-investors-crush-inflation-20211028.jpg",
    "site": "fool.com",
    "text": "These giant companies have the competitive advantage and consumer base to fight off inflation headwinds.",
    "url": "https://www.fool.com/investing/2021/10/28/2-top-stocks-help-investors-crush-inflation/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-28T06:15:00-04:00",
    "date_et": "2021-10-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-28 07:01:00",
    "publisher": "The Motley Fool",
    "title": "Is This Steady Healthcare Stock a Buy?",
    "image": "https://images.financialmodelingprep.com/news/is-this-steady-healthcare-stock-a-buy-20211028.jpg",
    "site": "fool.com",
    "text": "Johnson & Johnson beat analysts' earnings expectations in the third quarter. But does the valuation make the Dividend King a buy?",
    "url": "https://www.fool.com/investing/2021/10/28/is-this-steady-healthcare-stock-a-buy/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-28T07:01:00-04:00",
    "date_et": "2021-10-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-28 07:33:00",
    "publisher": "Reuters",
    "title": "Exclusive-Tens of millions of J&J COVID-19 shots sit at Baltimore factory -sources",
    "image": "https://images.financialmodelingprep.com/news/exclusivetens-of-millions-of-jj-covid19-shots-sit-at-20211028.jpg",
    "site": "reuters.com",
    "text": "An estimated 30 million to 50 million doses of Johnson & Johnson's COVID-19 vaccine made early this year sits idle in Emergent BioSolutions Inc's plant in Baltimore awaiting a green light from U.S. regulators to ship, two sources familiar with the matter said.",
    "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-emergent/exclusive-tens-of-millions-of-jj-covid-19-shots-sit-at-baltimore-factory-sources-idUSKBN2HI1AW",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-28T07:33:00-04:00",
    "date_et": "2021-10-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-28 08:01:00",
    "publisher": "The Motley Fool",
    "title": "What Investors Liked About Johnson & Johnson's Q3 Results",
    "image": "https://images.financialmodelingprep.com/news/what-investors-liked-about-johnson-johnsons-q3-results-20211028.jpg",
    "site": "fool.com",
    "text": "The healthcare giant delivered a solid performance in the third quarter.",
    "url": "https://www.fool.com/investing/2021/10/28/what-investors-liked-about-johnson-johnsons-q3-res/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-28T08:01:00-04:00",
    "date_et": "2021-10-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-28 08:53:38",
    "publisher": "Forbes",
    "title": "Up To 50 Million J&J Vaccine Doses Reportedly Sitting Unused In Baltimore Manufacturing Plant",
    "image": "https://images.financialmodelingprep.com/news/up-to-50-million-jj-vaccine-doses-reportedly-sitting-20211028.jpg",
    "site": "forbes.com",
    "text": "The vaccine maker is reportedly waiting for a green light from U.S. regulators before shipping out the doses.",
    "url": "https://www.forbes.com/sites/siladityaray/2021/10/28/up-to-50-million-jj-vaccine-doses-reportedly-sitting-unused-in-baltimore-manufacturing-plant/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-28T08:53:38-04:00",
    "date_et": "2021-10-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-28 09:10:00",
    "publisher": "Seeking Alpha",
    "title": "Bargain Alert! 2 High Yield Funds To Buy Now",
    "image": "https://images.financialmodelingprep.com/news/bargain-alert-2-high-yield-funds-to-buy-now-20211028.jpg",
    "site": "seekingalpha.com",
    "text": "Bargain Alert! 2 High Yield Funds To Buy Now",
    "url": "https://seekingalpha.com/article/4462320-bargain-alert-2-high-yield-funds-to-buy-now",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-28T09:10:00-04:00",
    "date_et": "2021-10-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-28 11:01:24",
    "publisher": "Seeking Alpha",
    "title": "Fortune's Change The World Report Included 5 Ideal Dividend Dogs",
    "image": "https://images.financialmodelingprep.com/news/fortunes-change-the-world-report-included-5-ideal-dividend-dogs-20211028.jpg",
    "site": "seekingalpha.com",
    "text": "A special report in Fortune Magazine October/November 2021 listed 53 Change The World (CTW) companies using plain old capitalism (including profits) to \"address society's unmet needs.\"",
    "url": "https://seekingalpha.com/article/4462875-fortunes-change-world-report-included-ideal-dividend-dogs",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-28T11:01:24-04:00",
    "date_et": "2021-10-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-29 11:39:01",
    "publisher": "Seeking Alpha",
    "title": "Is Johnson & Johnson Stock A Buy, Sell, Or Hold?",
    "image": "https://images.financialmodelingprep.com/news/is-johnson-johnson-stock-a-buy-sell-or-hold-20211029.jpeg",
    "site": "seekingalpha.com",
    "text": "The company is recovering from COVID induced headwinds and may develop a blockbuster vaccine to treat RSV.",
    "url": "https://seekingalpha.com/article/4463450-johnson-johnson-stock-buy-sell",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-29T11:39:01-04:00",
    "date_et": "2021-10-29"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-30 09:21:00",
    "publisher": "Reuters",
    "title": "J&J settles most Risperdal lawsuits, with $800 million in expenses",
    "image": "https://images.financialmodelingprep.com/news/jj-settles-most-risperdal-lawsuits-with-800-million-in-20211030.jpg",
    "site": "reuters.com",
    "text": "Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue and disclosed that it recorded $800 million in expenses in connection with the agreement.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-settles-most-risperdal-lawsuits-with-800-million-expenses-2021-10-30/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-30T09:21:00-04:00",
    "date_et": "2021-10-30"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-10-30 14:24:02",
    "publisher": "Benzinga",
    "title": "J&J Settles Anti-psychotic Drug Risperdal Lawsuits With $800 Million In Expenses",
    "image": "https://images.financialmodelingprep.com/news/jj-settles-antipsychotic-drug-risperdal-lawsuits-with-800-million-20211030.jpg",
    "site": "benzinga.com",
    "text": "Johnson & Johnson (NYSE: JNJ) says it has settled most of the lawsuits in the anti-psychotic drug Risperdal cases and has recorded $800 million in expenses in connection with the agreement. The medical devices and pharmaceuticals maker had almost 9000 cases over the Risperdal drug, and it accrued the entire legal expenses in the third quarter.",
    "url": "https://www.benzinga.com/news/21/10/23770001/j-j-settles-anti-psychotic-drug-risperdal-lawsuits-with-800-million-in-expenses",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-10-30T14:24:02-04:00",
    "date_et": "2021-10-30"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-11-01 12:21:00",
    "publisher": "Reuters",
    "title": "J&J, Costco settle lawsuits over recalled sunscreen",
    "image": "https://images.financialmodelingprep.com/news/jj-costco-settle-lawsuits-over-recalled-sunscreen-20211101.jpg",
    "site": "reuters.com",
    "text": "Johnson & Johnson and Costco Wholesale Corp have reached a tentative agreement to settle lawsuits over the presence of a cancer-causing substance in several recalled J&J sunscreen products.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-costco-settle-lawsuits-over-recalled-sunscreen-2021-11-01/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-11-01T12:21:00-04:00",
    "date_et": "2021-11-01"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-11-02 14:03:40",
    "publisher": "InvestorPlace",
    "title": "7 Stocks to Set Your Sights on as the ‘Hyperinflation' Debate Stirs Up",
    "image": "https://images.financialmodelingprep.com/news/7-stocks-to-set-your-sights-on-as-the-20211102.jpg",
    "site": "investorplace.com",
    "text": "Hyperinflation may not be imminent, but hedging against inflation is a wise move. These stocks and ETFs make that possible.",
    "url": "https://investorplace.com/2021/11/7-stocks-to-set-your-sights-on-as-the-hyperinflation-debate-stirs-up/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-11-02T14:03:40-04:00",
    "date_et": "2021-11-02"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-11-02 15:30:00",
    "publisher": "The Motley Fool",
    "title": "Is Johnson & Johnson a Good COVID Stock to Buy?",
    "image": "https://images.financialmodelingprep.com/news/is-johnson-johnson-a-good-covid-stock-to-buy-20211102.jpg",
    "site": "fool.com",
    "text": "The company's vaccine hasn't generated quite the same hype as its competitors.",
    "url": "https://www.fool.com/investing/2021/11/02/is-johnson-johnson-a-good-covid-stock-to-buy/",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-11-02T15:30:00-04:00",
    "date_et": "2021-11-02"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-11-02 18:44:37",
    "publisher": "Seeking Alpha",
    "title": "Endo: A Win In California But Equity Value Still A Question",
    "image": "https://images.financialmodelingprep.com/news/endo-a-win-in-california-but-equity-value-still-20211102.jpg",
    "site": "seekingalpha.com",
    "text": "Endo: A Win In California But Equity Value Still A Question",
    "url": "https://seekingalpha.com/article/4464661-endo-win-in-california-but-equity-value-still-question",
    "ticker": "JNJ",
    "event_date": "2021-10-19",
    "window_start": "2021-10-05",
    "window_end": "2021-11-02",
    "publishedDateET": "2021-11-02T18:44:37-04:00",
    "date_et": "2021-11-02"
  }
]